Global Blood Plasma Market Report: 2011 Edition New Market Reports by Koncept Analytics

March 11, 2012 - PRLog -- Recent scientific studies are leading to the discovery of new proteins in the blood plasma and their uses to treat hitherto unresolved medical conditions. The market for blood plasma products has shown continuous growth in the past years growing at a CAGR of around 10% during 2001-10 and is projected to expand steadily in the years to come.

The North American region is a major revenue generator in the global blood plasma industry, accounting for approximately 40% share of the worldwide market, followed by European Union, and other regions. The use of blood plasma products in developed countries is well established; however, their demand in emerging countries, such as China and India is persistently on the rise.

With scientific, technological advances in medical research in developed and developing countries, there is now much room for increased usage of IVIG. New indications are being explored whereby various blood plasma products are being put to new uses for treatment of old and new diseases. Further, the entry of new recombinant products, which compete with existing blood plasma products, have started a price competition creating a downward pressure on prices. The deficiency of A1PI is still an undiagnosed and untreated disease in North America which provides significant scope and potential for the increased use of blood plasma products in the treatment of the affected people.

Besides this, bleeding disorders and related diseases are growing requiring increased usage of blood plasma products. Ageing population is on the constant rise worldwide and the aged people are prone to develop diseases requiring more demand of blood derivatives. Furthermore, the economic growth is also responsible for higher utilization of blood plasma derivatives. Also, new proteins are being discovered in blood plasma, which are being put to new uses for treatment of various diseases.

Website - http://www.konceptanalytics.com/

Despite, several factors suggesting future growth of the market, the high prices of blood plasma products continues to be a significant challenge. Furthermore, even in the wake of improving economies and rising GDP's, income disparities keep the use of plasma derived products beyond the reach of numerous patients.

The leading players of the blood plasma market include: Baxter, Grifols, CSL, and Octapharma, among others, competing mainly on the basis of product pricing and performance, supply of the products, and continuous offering of new and innovative plasma derivatives. Moreover, the existence of several players operating at a domestic level, entry of new players, and agreements with government agencies, academic and research institutions make the plasma market landscape intensely competitive.

For more information click here http://www.konceptanalytics.com/reportDetail.aspx?reportI...

1. Overview

1.1 Introduction
1.2 Plasma Collection Process
1.3 Types of Blood Plasma Proteins
1.4 Value Chain of Plasma market

2. Blood Plasma Market Overview

2.1 Global Blood Plasma Market
2.2 Market by Segments

2.2.1 IVIG Market

Market Value
Uses of IVIG
Market Share
Other Statistics

2.2.2 Clotting Factors Market

Hemophilia B Treatment Revenues
Factor IX Market

2.2.3 Albumin Market
2.2.4 A1PI Market

2.3 Market by Region

2.2.1 The US Blood Plasma Market

Plasma Derivatives Market Value
IVIG Distribution Growth
Market Share

2.2.2 Canada Blood Plasma Market

Blood Derivatives Market Value
Immunoglobulin Market Share

2.2.3 China Blood Plasma Market

Market Overview
Market Segments
Albumin Market Value
Albumin Market Share
IVIG and Factor VIII Market
Factor VIII Market Forecast
Factor VIII Market Share

2.4 Industry Cost Structure

3. Market Dynamics

3.1 Key Trends

3.1.1 Potential for Increased Usage of IVIG
3.1.2 Discovery of New Conditions to Expand Market Potential
3.1.3 Treatments for A1PI Deficiency Limited to Prevention Only
3.1.4 New Recombinant Products to Start Price War

3.2 Growth Drivers

3.2.1 Growing Number of Bleeding Disorders
3.2.2 Growing Aging Population
3.2.3 Rising Global GDP per Capita
3.2.4 Discovery of New Proteins in Blood Plasma

3.3 Challenges

3.3.1 High Prices of Plasma Derived Drugs
3.3.2 Developing Countries–Delay in Switch to Recombinant Factors

4. Competitive Scenario

Competitive Overview
Market Share

5. Company Profiles

5.1 Baxter International

Business Description
Key Financials
Business Strategies
Investment in Research & Development
Growth through Sustainable Development

5.2 CSL Limited

Business Description
Key Financials
Business Strategies
Investment in New Facilities
Continuous Offering of New Products

5.3 Grifols

Business Description
Key Financials
Business Strategies
Geographical Diversification
Growth through Acquisitions

5.4 Octapharma

Business Description
Key Financials
Business Strategies
Constant Product Innovation
Investment in Research Facilities

6. Market Outlook

6.1 Market Forecast
6.2 Forecast Methodology

6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis

List of Charts

Plasma Derivatives Products per Liter of Plasma
The Plasma Chain
Value Chain of the Plasma-Derived Products Market
Global Blood Plasma Market, 2000-2010
Global Blood Plasma Market by Products, 2010
Global IVIG Market Revenues, 2004-2010
Uses of IVIG, 2010
IVIG Use per Inhabitant by Country, 2010
Global IVIG Market Share by Companies, 2010
Hemophilia B Treatment Revenues, 2011E
Factor VIII use per Inhabitant, 2010
A1PI Deficiency Counts in Europe and North America, 2010
The Global Plasma Market by Region, 2010
Blood Collection in the US
The US Plasma Derivatives Market, 2010
The US IVIG Distribution Growth, Sep08-May11
Number of Plasma Centers in the US, 2000-2010
Cost Structure of Operating Plasma Collection Center in the US
The US’ Blood Plasma Market by Companies, 2010
Canadian Blood Derivatives Market by Product Category, 2006-07 to 2009-10
Canada’s Immunoglobulin Market Share by Company, 2003-04 to 2010-11
Five-year Immunoglobulin trend by 1000 grams, 2006-07 to 2010-11
Chinese Blood Plasma Market by Product Category, 2010
China’s Albumin Market Sales, 2010
Albumin Prices in China, 2010
China’s Albumin Market Share by Companies, 2010
Albumin Usage Rate in China, 2010
Leading Suppliers of Albumin into China, 2010
China’s IVIG and Factor VIII Market, 2010
IVIG and Factor VIII Prices in China, 2010
China’s Factor VIII Market Share by Companies, Jan10-Oct10
Manufacturing Cost Split for Plasma Fractionation, September 2011
Global IVIG Consumption per Capita, 2010
Potential for Increased Use of IVIG in the US, 2010
A1PI - Largely Undiagnosed Disease in North America and EU
Global Ageing Population, 2005-2012F
Percentage of Recombinant Factor VIII in total Factor VIII Market, 2010
Grifols Market Share by Company, 2010
No. of Plasma Collection Centers of Leading in the US, 2010
Baxter’s Revenue Breakdown by Business Segments, 2010
Baxter’s Revenues and Net Income, 2006-2010
CSL’s Sales by Major Products, FY2011
Grifol’s Revenue Breakdown by Business Segments, 2010
Grifol’s Revenues and Net Income, 2006-2010
Octapahrma’s Revenues and Net Income, 2006-2010
Global Blood Plasma Market Forecasts, 2009-2014F

List of Tables

Output per Liter of Plasma
Plasma Donation vs. Whole Blood Donation
Recovered plasma vs. Source plasma
Forecast of Plasma for Fractionation by Region if IVIG is approved for Alzheimer’s disease Treatment, 2007-2018
Forecast of Plasma for Fractionation by Region if IVIG is not approved for Alzheimer’s disease Treatment, 2007-2018
Market Characteristics for Hemophilia B Treatments, 2010
Global Factor IX Market Estimates: Revenue Growth & Composition, 2011E-2020E
China Factor VIII Market Forecast, FY10-FY20E
IVIG being explored in New Indications, 2010
A1PI Products

# # #

Koncept Analytics, founded in 2005, works with the clients in developing an understanding of the various industries – segments and sub-segments, companies, competitors and suppliers.